Effect of Expanded Hemodialysis with Theranova® in Patients with COVID-19

María Luisa Serrano Salazar1, Jose Portolés1,2, Maria de Valdenebro Recio1

  • 1Nephrology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Blood Purification
|January 11, 2022
PubMed

Insights

Expanded hemodialysis (HDx) shows promise in managing severe COVID-19 patients requiring renal replacement therapy (RRT). HDx demonstrated superior cytokine and beta-2 microglobulin clearance, alongside reduced mortality compared to online hemodiafiltration (OL-HDF).

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Severe COVID-19 can trigger cytokine storms, necessitating immunosuppressive treatment.
  • Renal replacement therapy (RRT) offers a potential avenue for cytokine removal in COVID-19 patients with kidney injury.
  • Understanding the efficacy of different RRT techniques in managing cytokine profiles is crucial for improving patient outcomes.

Purpose of the Study:

  • To compare the effectiveness of online hemodiafiltration (OL-HDF) and expanded hemodialysis (HDx) in managing cytokine levels in COVID-19 patients requiring RRT.
  • To evaluate the impact of these RRT techniques on beta-2 microglobulin and albumin levels.
  • To assess the mortality rates associated with OL-HDF and HDx in this patient population.

Main Methods:

  • A prospective observational study involving 26 patients (18 COVID-19 on RRT, 8 controls).
  • COVID-19 patients on RRT were assigned to either OL-HDF or HDx based on Brescia group recommendations.
  • Cytokine, beta-2 microglobulin, and albumin levels were measured pre/post-dialysis and at 1-2 weeks, with comparisons made between techniques and a control group.

Main Results:

  • COVID-19 patients exhibited higher cytokine levels than controls, with those having acute kidney injury (AKI) showing even higher levels.
  • HDx demonstrated superior clearance of TNF-alpha and beta-2 microglobulin compared to OL-HDF.
  • Mortality rates were higher in the OL-HDF group than in the HDx group.

Conclusions:

  • HDx appears to be a safer and more effective RRT technique for COVID-19 patients with RRT requirements, offering better cytokine and beta-2 microglobulin clearance.
  • While not statistically significant due to sample size, preliminary data suggest HDx may reduce AKI incidence.
  • Further research is warranted, but HDx presents a promising approach for managing critically ill COVID-19 patients during current and future viral pandemics.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
171
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
259
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
387
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
9
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
874
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
10